False-positive cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarction

被引:239
作者
Larson, David M.
Menssen, Katie M.
Sharkey, Scott W.
Duval, Sue
Schwartz, Robert S.
Harris, James
Meland, Jeffrey T.
Unger, Barbara T.
Henry, Timothy D.
机构
[1] Abbott NW Hosp, Minneapolis Heart Inst Fdn, Minneapolis, MN 55407 USA
[2] Ridgeview Med Ctr, Dept Emergency Med, Waconia, MN USA
[3] Riverwood Healthcare Ctr, Aitkin, MN USA
[4] Northfield Hosp, Northfield, MN USA
[5] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2007年 / 298卷 / 23期
关键词
D O I
10.1001/jama.298.23.2754
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Allowing the emergency department physician to activate the cardiac catheterization laboratory is a key strategy to reduce door- to- balloon times in patients with ST- segment elevation myocardial infarction ( STEMI). There are limited data on the frequency of "false- positive" catheterization laboratory activation in patients undergoing percutaneous coronary intervention for suspected STEMI. Objective To determine the prevalence, etiology, and outcomes of false- positive cardiac catheterization laboratory activation in patients with a suspected STEMI. Design, Setting, and Patients Prospective registry from a regional system that includes transfer of patients with STEMI from 30 community and rural hospitals with pretransfer catheterization laboratory activation for percutaneous coronary intervention at a tertiary cardiovascular center in Minnesota. A total of 1345 patients were enrolled from March 2003 to November 2006. Main Outcome Measure Prevalence of false- positive catheterization laboratory activation in patients with suspected STEMI by 3 criteria: no culprit coronary artery, no significant coronary artery disease, and negative cardiac biomarker results. Results Of the 1335 patients with suspected STEMI who underwent angiography, 187 ( 14%; 95% confidence interval [ CI], 12.2%- 16.0%) had no culprit coronary artery and 127 ( 9.5%; 95% CI, 8.0%- 11.2%) did not have significant coronary artery disease. Cardiac biomarker levels were negative in 11.2% ( 95% CI, 9.6%-13.0%) of patients. The combination of no culprit artery with negative cardiac biomarker results was present in 9.2% ( 95% CI, 7.7%- 10.9%) of patients. Thirty- day mortality was 2.7% ( 95% CI, 0.4%- 5.0%) without vs 4.6% ( 95% CI, 3.4%- 5.8%) with a culprit coronary artery ( P =. 33). Conclusions The frequency of false- positive cardiac catheterization laboratory activation for suspected STEMI is relatively common in community practice, depending on the definition of false- positive. Recent emphasis on rapid door- to- balloon times must also consider the consequences of false- positive catheterization laboratory activation.
引用
收藏
页码:2754 / 2760
页数:7
相关论文
共 26 条
[1]   Task force 1: The ACCF and AHA codes of conduct in human subjects research [J].
Adams, RJ ;
Antman, EM ;
Kavey, REW .
CIRCULATION, 2004, 110 (16) :2512-2516
[2]   Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].
Alpert, JS ;
Antman, E ;
Apple, F ;
Armstrong, PW ;
Bassand, JP ;
de Luna, AB ;
Beller, G ;
Breithardt, G ;
Chaitman, BR ;
Clemmensen, P ;
Falk, E ;
Fishbein, MC ;
Galvani, M ;
Garson, A ;
Grines, C ;
Hamm, C ;
Jaffe, A ;
Katus, H ;
Kjekshus, J ;
Klein, W ;
Klootwijk, P ;
Lenfant, C ;
Levy, D ;
Levy, RI ;
Luepker, R ;
Marcus, F ;
Näslund, U ;
Ohman, M ;
Pahlm, O ;
Poole-Wilson, P ;
Popp, R ;
Alto, P ;
Pyörälä, K ;
Ravkilde, J ;
Rehnquist, N ;
Roberts, W ;
Roberts, R ;
Roelandt, J ;
Rydén, L ;
Sans, S ;
Simoons, ML ;
Thygesen, K ;
Tunstall-Pedoe, H ;
Underwood, R ;
Uretsky, BF ;
Van de Werf, F ;
Voipio-Pulkki, LM ;
Wagner, G ;
Wallentin, L ;
Wijns, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :959-969
[3]   Denying reperfusion or falsely declaring emergency: the dilemma posed by ST-segment elevation [J].
Barbagelata, Alejandro ;
Ware, David L. .
JOURNAL OF ELECTROCARDIOLOGY, 2006, 39 (04) :S73-S74
[4]   CARDIOVASCULAR COMPLICATIONS OF THROMBOLYTIC THERAPY IN PATIENTS WITH A MISTAKEN DIAGNOSIS OF ACUTE MYOCARDIAL-INFARCTION [J].
BLANKENSHIP, JC ;
ALMQUIST, AK .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (06) :1579-1582
[5]   Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour [J].
Boersma, E ;
Maas, ACP ;
Deckers, JW ;
Simoons, ML .
LANCET, 1996, 348 (9030) :771-775
[6]   Strategies for reducing the door-to-balloon time in acute myocardial infarction [J].
Bradley, Elizabeth H. ;
Herrin, Jeph ;
Wang, Yongfei ;
Barton, Barbara A. ;
Webster, Tashonna R. ;
Mattera, Jennifer A. ;
Roumanis, Sarah A. ;
Curtis, Jeptha P. ;
Nallamothu, Brahmajee K. ;
Magid, David J. ;
McNamara, Robert L. ;
Parkosewich, Janet ;
Loeb, Jerod M. ;
Krumholz, Harlan M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (22) :2308-2320
[7]   ST segment and T wave abnormalities not caused by acute coronary syndromes [J].
Brady, WJ .
EMERGENCY MEDICINE CLINICS OF NORTH AMERICA, 2006, 24 (01) :91-+
[8]   Electrocardiographic ST-segment elevation: Correct identification of acute myocardial infarction (AMI) and non-AMI syndromes by emergency physicians [J].
Brady, WJ ;
Perron, AD ;
Chan, T .
ACADEMIC EMERGENCY MEDICINE, 2001, 8 (04) :349-360
[9]   Door-to-balloon time with primary percutaneous coronary intervention for acute myocardial infarction impacts late cardiac mortality in high-risk patients and patients presenting early after the onset of symptoms [J].
Brodie, BR ;
Hansen, C ;
Stuckey, TD ;
Richter, S ;
VerSteeg, DS ;
Gupta, N ;
Downey, WE ;
Pulsipher, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (02) :289-295
[10]   PREVALENCE OF TOTAL CORONARY-OCCLUSION DURING THE EARLY HOURS OF TRANSMURAL MYOCARDIAL-INFARCTION [J].
DEWOOD, MA ;
SPORES, J ;
NOTSKE, R ;
MOUSER, LT ;
BURROUGHS, R ;
GOLDEN, MS ;
LANG, HT .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (16) :897-902